250mg Serobreath Fluticasone Salmeterol Inhaler

₹ 431/Pack

Packaging Size120 MDI
Packaging TypePack
BrandSerobreath
ManufacturerJohnlee
Shelf Life24month
CompositionSalmeterol
AvailabilityIn Stock
View in Hindi 250mg सेरोब्रीथ फ्लूटिकासोन साल्मेटरॉल इनहेलर
Salmeterol Xinafoate IP 25 Mcg + Fluticasone Propionate IP 250 Mcg 
Inhaled fluticasone and salmeterol is used to prevent asthma attacks and to treat chronic obstructive pulmonary disease (COPD). It is not used to relieve an asthma attack that has already started. For relief of an asthma attack that has already started, you should use another medicine.

Exports To: United States Of America | Canada | United Kingdom | Germany | Philippines

Find products similar to 250mg Serobreath Fluticasone Salmeterol Inhaler

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromMumbai
ShippingAs per delivery location

Product Image

250mg Serobreath Fluticasone Salmeterol Inhaler image 1250mg Serobreath Fluticasone Salmeterol Inhaler image 2250mg Serobreath Fluticasone Salmeterol Inhaler image 3

About the Company

GST Registration Year
2022
Legal Status of Firm
Partnership
Nature of Business
Trader - Retailer
Number of Employees
11 To 25 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Oct 2021
GST
27**********1Z0
Import Export Code (IEC)
*******62P
Exports to
United States Of America | Canada | United Kingdom | Germany | Philippines

Established in the year of 2022, We “Freed Pharma LLP.” are Wholesaler, Retailer and Exporter of an Pharmaceutical Tablets, Pharmaceutical Capsule, Pharmaceutical Injection, Medical Bandage etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Lalit Dengda, whose continual backing and direction have been useful to us for attaining exponential development in the current market.